NONA
GILD icon

Ninety One North America’s Gilead Sciences GILD Stock Holding History

Ninety One North America’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,149
Closed -$1.44M – 96
2016
Q4 		$1.44M Sell
20,149
-97,266
-83% -$7.23M 0.22% 78
2016
Q3 		$9.29M Buy
117,415
+2,517
+2% +$204K 1.25% 42
2016
Q2 		$9.59M Buy
114,898
+16,121
+16% +$1.43M 1.41% 25
2016
Q1 		$9.07M Buy
+98,777
New +$8.91M 1.51% 28

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ninety One North America's GILD Position: Q1 2017 in Review

Ninety One North America sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 20,149 shares — an estimated $1.44M sold.

Ninety One North America first reported a position in GILD in Q1 2016 and held it in 4 quarters. The position peaked at $9.59M in Q2 2016. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Ninety One North America reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Ninety One North America sold 20,149 Gilead Sciences shares in Q1 2017, an estimated $1.44M.
  • Ninety One North America first reported a position in Gilead Sciences in Q1 2016 and held it in 4 quarters.
  • Ninety One North America's Gilead Sciences position peaked at $9.59M in Q2 2016.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Ninety One North America's 13F filing for Q1 2017, filed 12 May 2017.